PSSE-Schroth vs General Exercises for Idiopathic Scoliosis, 12-Month RCT
ClinicalTrials.gov Studies
Summary
This randomized controlled trial registered on ClinicalTrials.gov evaluates whether Physiotherapeutic Scoliosis-Specific Exercises (PSSE-Schroth) are more effective than General Exercises at preventing curve progression in adolescents with idiopathic scoliosis over a 12-month intervention period. The 180-participant study uses Cobb angle progression and brace prescription rate as primary endpoints, with secondary outcomes including trunk rotation, quality of life, self-image, and body symmetry. Registered studies on ClinicalTrials.gov are informational records and do not create regulatory obligations.
“This randomized controlled trial evaluates the effectiveness of Physiotherapeutic Scoliosis-Specific Exercises (PSSE-Schroth) compared with General Exercises in adolescents with idiopathic scoliosis over a 12-month intervention period.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This ClinicalTrials.gov registration records a randomized controlled trial comparing two exercise-based interventions for adolescent idiopathic scoliosis: Physiotherapeutic Scoliosis-Specific Exercises using the Schroth method versus standard General Exercises. The 12-month study plans to enroll 180 participants and measure primary outcomes of Cobb angle progression and brace prescription rates, along with secondary measures of trunk rotation, quality of life, self-image, and body symmetry. Healthcare providers and clinical investigators conducting or referring patients for scoliosis treatment should note this comparative effectiveness study as it may inform future treatment protocols. The registration does not impose any compliance requirements.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Comparative Effectiveness of Physiotherapeutic Scoliosis-Specific Exercises With Idiopathic Scoliosis
N/A NCT07552662 Kind: NA Apr 27, 2026
Abstract
This randomized controlled trial evaluates the effectiveness of Physiotherapeutic Scoliosis-Specific Exercises (PSSE-Schroth) compared with General Exercises in adolescents with idiopathic scoliosis over a 12-month intervention period. Primary outcomes include Cobb angle progression and brace prescription rate. Secondary outcomes include trunk rotation, quality of life, self-image, and body symmetry.
Conditions: Scoliosis Idiopathic, Exercise, Scroth
Interventions: PSSE-Schroth Exercises, General Exercises
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.